Lowering A1C, improving blood pressure, reducing sleep apnea risk, supporting mobility, or protecting long-term cardiovascular health may also shape the treatment decision
Adjusted body weight is calculated as ideal body weight plus 25% of the difference between actual and ideal weight
Shortened spadin analogs display better TREK-1 inhibition, in vivo stability and antidepressant activity
The cumulative incidence was 6.7% for semaglutide versus 0.8% for the non-GLP-1 RA group over 36 months
In a market driven by community HCPs, how do their perspectives compare to those of academic HCPs, and what influence do academic HCPs have on the overall prescribing patterns with multiple options on the market
Heres the reality: While animal studies show promise, large-scale human clinical trials for cosmetic skin rejuvenation are limited